This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Aix-Marseille Université, Assistance Publique Hopitaux De Marseille, Centre National De La Recherche Scientifique. Active years: 2022.
Company Filing History:
1 out of 13 
1 out of 18 
1 out of 5,383 
Years Active: 2022
Title: David Daude: Innovator in Enzyme Technology
Introduction
David Daude is a notable inventor based in Marseille, France. He has made significant contributions to the field of enzyme technology, particularly through his innovative work on mutated phosphotriesterase enzymes. His research focuses on enhancing the stability and activity of these enzymes, which play a crucial role in degrading harmful organophosphorus compounds.
Latest Patents
David Daude holds 1 patent for his work on mutated PTE enzymes. This patent discloses various mutated phosphotriesterase enzymes that exhibit improved stability and activity. The advancements in this area are particularly important for applications aimed at degrading organophosphorus compounds, which are often used in pesticides and chemical warfare agents.
Career Highlights
Throughout his career, David has worked with esteemed organizations such as La Fondation Mediterranee Infection and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
David has collaborated with notable colleagues, including Eric Chabriere and Mikael Elias. These partnerships have further enriched his research and have led to advancements in enzyme technology.
Conclusion
David Daude's innovative work in the field of enzyme technology, particularly with mutated phosphotriesterase enzymes, showcases his commitment to addressing environmental challenges. His contributions are vital for the development of effective solutions to degrade harmful compounds.